---
$id: https://graph.org.ai/products/commodity/51281819
$type: Product
source: UNSPSC
code: "51281819"
title: "Epirubicin hydrochloride"
class: "51281800"
classTitle: "Anthracyclines"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Epirubicin hydrochloride

**UNSPSC Code**: 51281819
**Class**: [Anthracyclines](Anthracyclines.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antineoplastic antibiotic with the molecular formula C27H29NO11.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 22966TX7J5, chemically known as 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8s-cis)- but more generally known as epirubicin hydrochloride, which bears US NIH Compound Identifier 32874. European Medicines Agency schedules Epirubicin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01915MIG. Most nations, for tariff and trade purposes, schedule epirubicin hydrochloride under HS 29419000 and SITC 54139. As of Q4 2014, EPIRUBICIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Epirubicin hydrochloride bears US NLM identifiers UMLS ID C0701345 and NCI Concept Code C474. SMILES: C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3C2C(C4C(C3O)C(=O)C5CCCC(C5C4=O)OC)O)(C(=O)CO)O)N)O.CL.

